Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Total Current Liabilities: 2020-2025

Historic Total Current Liabilities for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Sep 2025 value amounting to $99.8 million.

  • Arcutis Biotherapeutics' Total Current Liabilities fell 42.14% to $99.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $99.8 million, marking a year-over-year decrease of 42.14%. This contributed to the annual value of $81.0 million for FY2024, which is 73.59% up from last year.
  • Arcutis Biotherapeutics' Total Current Liabilities amounted to $99.8 million in Q3 2025, which was down 4.01% from $103.9 million recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Total Current Liabilities ranged from a high of $172.4 million in Q3 2024 and a low of $13.3 million during Q2 2021.
  • For the 3-year period, Arcutis Biotherapeutics' Total Current Liabilities averaged around $73.6 million, with its median value being $51.4 million (2024).
  • Per our database at Business Quant, Arcutis Biotherapeutics' Total Current Liabilities spiked by 311.63% in 2024 and then tumbled by 42.14% in 2025.
  • Quarterly analysis of 5 years shows Arcutis Biotherapeutics' Total Current Liabilities stood at $33.3 million in 2021, then rose by 13.45% to $37.8 million in 2022, then grew by 23.44% to $46.7 million in 2023, then surged by 73.59% to $81.0 million in 2024, then crashed by 42.14% to $99.8 million in 2025.
  • Its Total Current Liabilities was $99.8 million in Q3 2025, compared to $103.9 million in Q2 2025 and $91.1 million in Q1 2025.